ProCE Banner Activity

Histology-Agnostic Biomarkers in Advanced Gastrointestinal Malignancies

Slideset Download
Download these slides from our 2020 ASCO-GI live satellite symposium on histology-agnostic biomarkers in advanced GI cancers including MMR/MSI and NTRK fusions.

Released: January 23, 2020

Expiration: January 21, 2021

No longer available for credit.

Share

Faculty

Pashtoon M. Kasi

Pashtoon M. Kasi, MD, MS

Director 
Colon Cancer Research 
Weill Cornell Medicine
Director 
Liquid Biopsy Research 
Englander Institute of Precision Medicine 
New York, New Yotk

John L. Marshall

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Pashtoon M. Kasi, MD, MS

Director 
Colon Cancer Research 
Weill Cornell Medicine
Director 
Liquid Biopsy Research 
Englander Institute of Precision Medicine 
New York, New Yotk

Pashtoon Kasi, MD, has disclosed that he has received consulting fees from Foundation Medicine, Ipsen, Natera, and Taiho and funds for research support from Amgen, Array, AstraZeneca, BTG, Clovis, and RenovoRx.

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

John L. Marshall, MD, has disclosed that he has received consulting fees from Amgen, Bayer, Celgene, Genentech, Merck, and Taiho; salary from Caris Life Sciences and Indivumed; and fees for non-CME services from Amgen, Bayer, Celgene, Genentech, Merck, and Taiho.